PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTS

Background: Glaucoma-induced visual impairment negatively influences quality of life of oncologic patients. Yet, tumor in itself and methods of its treatment may promote glaucoma progression. Aim: To study characteristics and course of primary open-angle glaucoma in oncologic patients. Materials and...

Full description

Bibliographic Details
Main Authors: A. A. Ryabtseva, E. E. Grishina
Format: Article
Language:Russian
Published: MONIKI 2016-02-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://www.almclinmed.ru/jour/article/view/215
_version_ 1818653178979155968
author A. A. Ryabtseva
E. E. Grishina
author_facet A. A. Ryabtseva
E. E. Grishina
author_sort A. A. Ryabtseva
collection DOAJ
description Background: Glaucoma-induced visual impairment negatively influences quality of life of oncologic patients. Yet, tumor in itself and methods of its treatment may promote glaucoma progression. Aim: To study characteristics and course of primary open-angle glaucoma in oncologic patients. Materials and methods: We analyzed case reports of 19 oncologic patients after primary open-angle glaucoma-related sinus trabeculectomy (34 eyes) and laser cyclopexy (1 eye). Diagnosed malignancies included colorectal cancer in 5 patients, uterine body and cervical cancer in 4 patients, chronic lymphocytic leukemia in 1 patient, renal cell carcinoma in 1 patient, adrenal cancer in 1 patient, prostatic cancer in 1 patient, breast cancer in 1 patient, vulvar cancer in 1 patient, tongue root cancer in 1 patient. Antiglaucomatous surgery was accomplished during the first 5 years from the diagnosis of tumor in 14 patients. In 9 patients, chemotherapy or hormone therapy was continued by the time of surgery. Follow-up of the patients was undertaken in 4–12 months after the antiglaucomatous operation; it included routine ophthalmological examination and dry eye syndrome functional tests. Results: Duration of postoperative period was 4 months or more. All patients had uveitis postoperatively. During late postoperative period, choroidal detachment was diagnosed in 4 patients. Bleb scarring was found in 2 patients. All patients received hypotensive treatment postoperatively including selective and non-selective beta-adrenergic blockers. Conjunctival and corneal xerosis was observed in all patients. Conclusion: In oncologic patients undergoing antiglaucomatous surgery, long-term (4 months or more) postoperative anti-inflammatory therapy is needed along with monthly ophthalmological follow-up during the first year after the operation. In patients with ongoing cytostatic drug treatment, artificial tear should be administrated.
first_indexed 2024-12-17T02:33:47Z
format Article
id doaj.art-6de9b3e6891d46fdaee7a5e1a6cb244e
institution Directory Open Access Journal
issn 2072-0505
2587-9294
language Russian
last_indexed 2024-12-17T02:33:47Z
publishDate 2016-02-01
publisher MONIKI
record_format Article
series Alʹmanah Kliničeskoj Mediciny
spelling doaj.art-6de9b3e6891d46fdaee7a5e1a6cb244e2022-12-21T22:06:54ZrusMONIKIAlʹmanah Kliničeskoj Mediciny2072-05052587-92942016-02-01036373910.18786/2072-0505-2015-36-37-39215PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTSA. A. Ryabtseva0E. E. Grishina1Moscow Regional Research and Clinical Institute (MONIKI)Moscow Regional Research and Clinical Institute (MONIKI)Background: Glaucoma-induced visual impairment negatively influences quality of life of oncologic patients. Yet, tumor in itself and methods of its treatment may promote glaucoma progression. Aim: To study characteristics and course of primary open-angle glaucoma in oncologic patients. Materials and methods: We analyzed case reports of 19 oncologic patients after primary open-angle glaucoma-related sinus trabeculectomy (34 eyes) and laser cyclopexy (1 eye). Diagnosed malignancies included colorectal cancer in 5 patients, uterine body and cervical cancer in 4 patients, chronic lymphocytic leukemia in 1 patient, renal cell carcinoma in 1 patient, adrenal cancer in 1 patient, prostatic cancer in 1 patient, breast cancer in 1 patient, vulvar cancer in 1 patient, tongue root cancer in 1 patient. Antiglaucomatous surgery was accomplished during the first 5 years from the diagnosis of tumor in 14 patients. In 9 patients, chemotherapy or hormone therapy was continued by the time of surgery. Follow-up of the patients was undertaken in 4–12 months after the antiglaucomatous operation; it included routine ophthalmological examination and dry eye syndrome functional tests. Results: Duration of postoperative period was 4 months or more. All patients had uveitis postoperatively. During late postoperative period, choroidal detachment was diagnosed in 4 patients. Bleb scarring was found in 2 patients. All patients received hypotensive treatment postoperatively including selective and non-selective beta-adrenergic blockers. Conjunctival and corneal xerosis was observed in all patients. Conclusion: In oncologic patients undergoing antiglaucomatous surgery, long-term (4 months or more) postoperative anti-inflammatory therapy is needed along with monthly ophthalmological follow-up during the first year after the operation. In patients with ongoing cytostatic drug treatment, artificial tear should be administrated.https://www.almclinmed.ru/jour/article/view/215primary open-angle glaucomaoncologic patientuveitisdry eye syndrome
spellingShingle A. A. Ryabtseva
E. E. Grishina
PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTS
Alʹmanah Kliničeskoj Mediciny
primary open-angle glaucoma
oncologic patient
uveitis
dry eye syndrome
title PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTS
title_full PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTS
title_fullStr PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTS
title_full_unstemmed PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTS
title_short PRIMARY OPEN-ANGLE GLAUCOMA IN ONCOLOGIC PATIENTS
title_sort primary open angle glaucoma in oncologic patients
topic primary open-angle glaucoma
oncologic patient
uveitis
dry eye syndrome
url https://www.almclinmed.ru/jour/article/view/215
work_keys_str_mv AT aaryabtseva primaryopenangleglaucomainoncologicpatients
AT eegrishina primaryopenangleglaucomainoncologicpatients